Drug Trial Radar · NCT04774536
Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
9
Planned (sponsor's estimate)
Start
Aug 22, 2025
Primary completion
Mar 1, 2030
Study completion Mar 1, 2030
Sponsor
- Lead sponsor
- Mark Walters, MDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of California, Los Angeles; University of California, Berkeley
- First posted
- Mar 1, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open label, non-randomized, 2-center, phase 1/2 trial of a single infusion of sickle allele modified cluster of differentiation (CD34+) hematopoietic stem progenitor cells (HSPCs) in subjects with in subjects ≥12 years old to 35 years old severe Sickle Cell Disease (SCD). The study will evaluate the hematopoietic stem cell transplantation (HSCT) using CRISPR/Cas9 edited red blood cells (known as CRISPR\_SCD001 Drug Product).
Conditions
- Sickle Cell Disease
Interventions
CRISPR_SCD001Drug
CRISPR\_SCD001 is administered by IV infusion following myeloablative conditioning with busulfan.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse events and grade 3 or higher serious adverse events, using the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE)Time frame: 24 months post-transplant
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
University of California, Davis
Davis, California · Recruiting
University of California, Los Angeles
Los Angeles, California · Recruiting
UCSF Benioff Children's Hospital
Oakland, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.